Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of YD0293 in Healthy Subjects

NCT07098091 · clinicaltrials.gov ↗

PHASE1

Phase

ENROLLING_BY_INVITATION

Status

78

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Participants

Interventions

DRUG: YD0293
DRUG: YD0293 placebo

Sponsor

Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.